LY550410 is a small-molecule ATP-competitive inhibitor against type I TGF-β receptor kinase , which contains heteroaryl rings for potent binding to the kinase-domain active site. LY550410 modulates TGF-β signalling, thereby regulates gene expression and ultimately cell growth. LY550410 is promising for research of cancers.